Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 16, 2010

View Archived Issues

4-PBA and curcumin enhance protein expression of mutant ATP7B / News in Context

Genzyme reports 2-year data from phase II Gaucher's disease trial

Bristol-Myers Squibb reports results from fourth quarter 2009, ended December 31

Shionogi files additional application in Japan for pediatric use of Rapiacta

Oxigene presents update on development of Zybrestat

3SBio submits application in China for phase I clinical trial of NuPIAO

Debiopharm's Clinical Trial Application for Debio-0932 approved in France

Helix reports preliminary results from phase II study of topical interferon alpha-2b

ADX-71943 demonstrates analgesic effects in preclinical pain models

Repros submits response to FDA regarding Androxal in hypogonadism

LJ-001, a broad-spectrum antiviral targeting the viral lipid membrane

Solvay claims novel adenosine A1 receptor antagonists

Amakem starts operations to discover and develop novel kinase inhibitors

Bristol-Myers Squibb claims MAP kinase inhibitors for inflammatory disorders

Millennium Pharmaceuticals patents novel proteasome inhibitors

Older vaccines provide protection against 2009 pandemic H1N1 influenza

Genentech identifies new Janus kinase inhibitors

Roche claims monoamine reuptake inhibitors for the treatment of affective disorders

HDAC inhibitor SAHA restores activity of mutant CFTR in vitro

Fingolimod shows clinical benefit in two phase III trials in relapsing-remitting MS

AVI BioPharma receives grants for Duchenne muscular dystrophy drug development

Toyama initiates U.S. phase II trial for its anti-influenza drug candidate, T-705

Abbott acquires Solvay Pharmaceuticals for EUR 4.5 billion

AstraZeneca and Rigel sign license agreement for fostamatinib disodium in RA

Pharmaxis completes phase I clinical trial of PXS-25 in healthy volunteers

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...